ENPP2 and Stroke: Overall, Bitar, Uphaus, Thalman and colleagues demonstrated the involvement of lipidsignalling in stroke outcome by different approaches (cell-type specific deletion, geneticmodels, and pharmacological inhibition) which allows validation of ATX as a potential targetfor stroke treatment.